The Importance of Follow-up in Patients with Premature Ejaculation

Journal of Sexual Medicine

Volumn 8, Issue SUPPL. 4, 2011, Pages 353-359

  Moncada, Ignacio ^a  

^a Hospital Sanitas La Zarzuela   (Spain)

Author keywords

Consultation; Follow up; Managing; Monitoring; Premature Ejaculation

Indexed keywords

DAPOXETINE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ARTICLE; COMORBIDITY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; TREATMENT RESPONSE;

EID: 80053555662     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02424.x     Document Type: Article

References (37)

1. Sadeghi-Nejad H, Watson R. Premature ejaculation: Current medical treatment and new directions (CME). J Sex Med 2008;5:1037-50.
2. Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B, Derogatis L, Litwin M, Meuleman E, O'Leary M, Quirk F, Sadovsky R, Seftel A. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 2004;1:49-57.
3. Maniaci MJ, Heckman MG, Dawson NL. Functional health literacy and understanding of medications at discharge. Mayo Clin Proc 2008;83:554-8.
4. Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB. Closing the loop: Physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003;163:83-90.
5. Crane JA. Patient comprehension of doctor-patient communication on discharge from the emergency department. J Emerg Med 1997;15:1-7.
6. Palmer NR, Stuckey BG. Premature ejaculation: A clinical update. Med J Aust 2008;188:662-6.
7. Dunn JD, Tierneey JG. A step therapy algorithm for the treatment and management of chronic depression. Am J Manag Care 2006;12(12 suppl):S335-43.
8. Hatzimouratidis K, Moysidis K, Bekos A, Tsimtsiou Z, Ioannidis E, Hatzichristou D. Treatment strategy for "non-responders" to tadalafil and vardenafil: A real-life study. Eur Urol 2006;50:126-32; discussion 32-3.
9. Hatzimouratidis K, Hatzichristou DG. Phosphodiesterase type 5 inhibitors: Unmet needs. Curr Pharm Des 2009;15:3476-85.
10. Salonia A, Gallina A, Zanni G, Briganti A, Deho F, Sacca A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;53:564-70.
11. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, Ahn TY. Disorders of orgasm and ejaculation in men. J Sex Med 2010;7(4 Pt 2):1668-86.
12. Rosen RC, Leiblum SR. Treatment of sexual disorders in the 1990s: An integrated approach. J Consult Clin Psychol 1995;63:877-90.
13. Perelman MA. The impact of the new sexual pharmaceuticals on sex therapy. Curr Psychiatry Rep 2001;3:195-201.
14. Jackson G, Arver S, Banks I, Stecher VJ. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. Int J Clin Pract 2010;64:497-504.
15. Dean J, Klep R, Aquilina JW. Counterfeit dapoxetine sold on the Internet contains undisclosed sildenafil. Int J Clin Pract 2010;64:1319-22.
16. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJ, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM, International Society for Sexual Medicine. International society for sexual medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010;7:2947-69.
17. Rosen RC, Althof S. Impact of premature ejaculation: The psychological, quality of life, and sexual relationship consequences. J Sex Med 2008;5:1296-307.
18. Rowland DL, Patrick DL, Rothman M, Gagnon DD. The psychological burden of premature ejaculation. J Urol 2007;177:1065-70.
19. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005;2:358-67.
20. Hellstrom WJ, Heintz JW. Treatment of premature ejaculation: New drugs and treatment strategies. Curr Urol Rep 2006;7:473-8.
21. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking. Eur Urol 2007;51:816-23; discussion 24.
22. Sotomayor M. The burden of premature ejaculation: The patient's perspective. J Sex Med 2005;2:S110-4.
23. Salonia A, Rocchini L, Sacca A, Pellucchi F, Ferrari M, Carro UD, Ribotto P, Gallina A, Zanni G, Deho F, Rigatti P, Montorsi F. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. J Sex Med 2009;6:2868-77.
24. Broderick GA. Premature ejaculation: On defining and quantifying a common male sexual dysfunction. J Sex Med 2006;3:S295-302.
25. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen RC, Rowland DL, Segraves R. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;5:1590-606.
26. Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice. BJU Int 2009;103:358-64.
27. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, Bull S. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-52.
28. PRILIGY. Summary of product characteristics. 2008.
29. Linton KD, Wylie KR. Recent advances in the treatment of premature ejaculation. Drug Des Devel Ther 2010;4:1-6.
30. Rosenberg MT, Sadovsky R. Identification and diagnosis of premature ejaculation. Int J Clin Pract 2007;61:903-8.
31. Stevenson RW, Szasz G, Maurice WL, Miles JE. How to become comfortable talking about sex to your patients. Can Med Assoc J 1983;128:797-800.
32. Revicki D, Howard K, Hanlon J, Mannix S, Greene A, Rothman M. Characterizing the burden of premature ejaculation from a patient and partner perspective: A multi-country qualitative analysis. Health Qual Life Outcomes 2008;6:33.
33. Sadovsky R. The role of the primary care clinician in the management of erectile dysfunction. Rev Urol 2002;4(suppl 3):S54-63.
34. Richardson D, Wood K, Goldmeier D. A qualitative pilot study of Islamic men with lifelong premature (rapid) ejaculation. J Sex Med 2006;3:337-43.
35. Richardson D, Goldmeier D. Premature ejaculation-Does country of origin tell us anything about etiology? J Sex Med 2005;2:508-12.
36. Petok WD. Overcoming barriers to care: Sexual dysfunction in religious couples. Sex Reprod Menopause 2010;8:29-32.
37. Faber B, Christensen HB, Bjorner JB. [Premature ejaculation-Results of treatment of men of 2 different cultural backgrounds]. Ugeskr Laeger 1992;154:1638-41.